{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T20:05:24Z","timestamp":1769025924386,"version":"3.49.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1097\/maj.0b013e31816b874b","type":"journal-article","created":{"date-parts":[[2008,6,9]],"date-time":"2008-06-09T07:20:39Z","timestamp":1212996039000},"page":"477-483","source":"Crossref","is-referenced-by-count":2,"title":["Brain Natriuretic Peptide in Cardiovascular Diseases"],"prefix":"10.1016","volume":"335","author":[{"given":"Andreas","family":"Synetos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Aznaouridis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stamatios","family":"Lerakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stamatios","family":"Lerakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/MAJ.0b013e31816b874b_bb0010","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/01.RES.4.1.85","article-title":"Evidence of the atrial location of receptors influencing urine flow","volume":"4","author":"Henry","year":"1956","journal-title":"Circ Res"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0015","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1016\/S0021-9258(18)94025-1","article-title":"Atrial natriuretic factor","volume":"264","author":"Inagami","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0020","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1503\/cmaj.060236","article-title":"Natriuretic peptides in the diagnosis and management of heart failure","volume":"175","author":"Felker","year":"2006","journal-title":"CMAJ"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0025","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/01.CIR.90.3.1129","article-title":"Three peptides from the atrial natriuretic factor prohormone amino terminus lower blood pressure and produce diuresis, natriuresis, and\/or kaliuresis in humans","volume":"90","author":"Vesely","year":"1994","journal-title":"Circulation"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0030","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.carpath.2006.01.001","article-title":"Serum biomarkers for heart failure","volume":"15","author":"Jarolim","year":"2006","journal-title":"Cardiovasc Pathol"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0035","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2005.08.022","volume":"46","author":"Hunt","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0040","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1053\/euhj.2001.2783","article-title":"Guidelines for the diagnosis and treatment of chronic heart failure","volume":"22","author":"Remme","year":"2001","journal-title":"Eur Heart J"},{"issue":"5Pt 1","key":"10.1097\/MAJ.0b013e31816b874b_bb0045","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/S0002-8703(97)80014-2","article-title":"Digitalis increases brain natriuretic peptide in patients with severe congestive heart failure","volume":"134","author":"Tsutamoto","year":"1997","journal-title":"Am Heart J"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0050","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1136\/hrt.74.5.502","article-title":"Effect of low dose beta blockers on atrial and ventricular (B type) natriuretic factor in heart failure: a double blind, randomised comparison of metoprolol and a third generation vasodilating beta blocker","volume":"74","author":"Sanderson","year":"1995","journal-title":"Br Heart J"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0055","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0735-1097(01)01116-0","article-title":"Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure","volume":"37","author":"Tsutamoto","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0060","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/S0735-1097(98)00464-1","article-title":"High- versus low-dose ACE inhibition in chronic heart failure: a double-blind, placebo-controlled study of imidapril","volume":"32","author":"van Veldhuisen","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0065","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1161\/01.CIR.0000036747.68104.AC","article-title":"Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: the Valsartan Heart Failure Trial (Val-HeFT)","volume":"106","author":"Latini","year":"2002","journal-title":"Circulation"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0070","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1023\/A:1027343606509","article-title":"Amiodarone decreases plasma brain natriuretic peptide level in patients with heart failure and ventricular tachyarrhythmia","volume":"17","author":"Shiga","year":"2003","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0075","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/S0002-8703(99)70079-7","article-title":"Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy","volume":"138","author":"Murdoch","year":"1999","journal-title":"Am Heart J"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0080","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/01.CIR.0000025242.79963.4C","article-title":"B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study","volume":"106","author":"McCullough","year":"2002","journal-title":"Circulation"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0085","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.amjcard.2004.12.032","article-title":"The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study","volume":"95","author":"Januzzi","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0090","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.jacc.2004.06.015","article-title":"Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath","volume":"44","author":"Maisel","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0095","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ejheart.2004.01.001","article-title":"N-terminal pro brain natriuretic peptide in arterial hypertension\u2014a marker for left ventricular dimensions and prognosis","volume":"6","author":"Hildebrandt","year":"2004","journal-title":"Eur J Heart Fail"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0100","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1001\/jama.294.15.1944","article-title":"Does this dyspneic patient in the emergency department have congestive heart failure?","volume":"294","author":"Wang","year":"2005","journal-title":"Jama"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0105","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJMoa020233","article-title":"Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure","volume":"347","author":"Maisel","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0110","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ahj.2005.02.031","article-title":"A validated clinical and biochemical score for the diagnosis of acute heart failure: the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Acute Heart Failure Score","volume":"151","author":"Baggish","year":"2006","journal-title":"Am Heart J"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0115","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1056\/NEJMoa031681","article-title":"Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea","volume":"350","author":"Mueller","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0120","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1161\/01.CIR.0000016642.15031.34","article-title":"B-type natriuretic peptide predicts sudden death in patients with chronic heart failure","volume":"105","author":"Berger","year":"2002","journal-title":"Circulation"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0125","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.jacc.2006.10.081","article-title":"Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study","volume":"49","author":"Jourdain","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0130","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.ejheart.2006.04.004","article-title":"NTproBNP-guided drug treatment for chronic heart failure: design and methods in the \u201cBATTLESCARRED\u201d trial","volume":"8","author":"Lainchbury","year":"2006","journal-title":"Eur J Heart Fail"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0135","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/S0140-6736(00)02060-2","article-title":"Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations","volume":"355","author":"Troughton","year":"2000","journal-title":"Lancet"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0140","first-page":"155","article-title":"Incremental prognostic implications of brain natriuretic peptide, cardiac sympathetic nerve innervation, and noncardiac disorders in patients with heart failure","volume":"45","author":"Kyuma","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0145","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/bmj.330.7492.625","article-title":"How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review","volume":"330","author":"Doust","year":"2005","journal-title":"BMJ"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0150","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1161\/01.CIR.0000054164.99881.00","article-title":"Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT)","volume":"107","author":"Anand","year":"2003","journal-title":"Circulation"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0155","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jacc.2003.09.044","article-title":"Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure","volume":"43","author":"Logeart","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0160","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(97)03034-1","article-title":"Biochemical detection of left-ventricular systolic dysfunction","volume":"351","author":"McDonagh","year":"1998","journal-title":"Lancet"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0165","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1161\/01.CIR.0000130845.38133.8F","article-title":"Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction: a community-based study","volume":"109","author":"Redfield","year":"2004","journal-title":"Circulation"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0170","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jacc.2003.07.037","article-title":"Elevation of plasma brain natriuretic peptide is a hallmark of diastolic heart failure independent of ventricular hypertrophy","volume":"43","author":"Yamaguchi","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0175","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1161\/01.CIR.0000070020.79932.DB","article-title":"Brain natriuretic peptide as a predictor of adverse outcome in patients with pulmonary embolism","volume":"107","author":"ten Wolde","year":"2003","journal-title":"Circulation"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0180","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0735-1097(02)02032-6","article-title":"Brain natriuretic peptide levels predict functional capacity in patients with chronic heart failure","volume":"40","author":"Kruger","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0185","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1161\/01.CIR.62.1.42","article-title":"Hemodynamic determinants of prognosis of aortic valve replacement in critical aortic stenosis and advanced congestive heart failure","volume":"62","author":"Carabello","year":"1980","journal-title":"Circulation"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0190","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1161\/CIRCULATIONAHA.106.654210","article-title":"B-type natriuretic peptide in low-flow, low-gradient aortic stenosis: relationship to hemodynamics and clinical outcome: results from the Multicenter Truly or Pseudo-Severe Aortic Stenosis (TOPAS) study","volume":"115","author":"Bergler-Klein","year":"2007","journal-title":"Circulation"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0195","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2362.2007.01810.x","article-title":"Natriuretic peptides and myocardial oxygen supply-to-demand ratio in patients with aortic stenosis","volume":"37","author":"Wagner","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0200","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.amjcard.2005.06.092","article-title":"Usefulness of an elevated B-type natriuretic peptide in predicting survival in patients with aortic stenosis treated without surgery","volume":"96","author":"Nessmith","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0205","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.amjcard.2005.11.085","article-title":"Utility of plasma N-terminal brain natriuretic peptide as a marker of functional capacity in patients with chronic severe mitral regurgitation","volume":"97","author":"Yusoff","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0210","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0828-282X(07)70758-4","article-title":"Usefulness of the brain natriuretic peptide to atrial natriuretic peptide ratio in determining the severity of mitral regurgitation","volume":"23","author":"Shimamoto","year":"2007","journal-title":"Can J Cardiol"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0215","first-page":"305","article-title":"[The value of repeated determinations of brain natriuretic peptide for the diagnosis of unstable angina]","volume":"96","author":"Leroy","year":"2003","journal-title":"Arch Mal Coeur Vaiss"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0220","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0735-1097(02)01986-1","article-title":"N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation","volume":"40","author":"Jernberg","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0225","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1159\/000176706","article-title":"Relationship between plasma level of brain natriuretic peptide and myocardial infarct size","volume":"85","author":"Arakawa","year":"1994","journal-title":"Cardiology"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0230","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1053\/euhj.1999.2045","article-title":"Profile of plasma N-terminal proBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction","volume":"21","author":"Talwar","year":"2000","journal-title":"Eur Heart J"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0235","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1161\/01.CIR.88.1.82","article-title":"Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction","volume":"88","author":"Morita","year":"1993","journal-title":"Circulation"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0240","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/0140-6736(93)93126-L","article-title":"Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction","volume":"341","author":"Motwani","year":"1993","journal-title":"Lancet"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0245","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/j.jacc.2004.07.057","article-title":"Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia","volume":"44","author":"Sabatine","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0250","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1161\/01.CIR.89.4.1573","article-title":"Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction","volume":"89","author":"Omland","year":"1994","journal-title":"Circulation"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0255","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/j.jacc.2003.07.015","article-title":"N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease","volume":"42","author":"Jernberg","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0260","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S0002-9149(00)01207-8","article-title":"Comparison of a 60- versus 90-minute determination of ST-segment resolution after thrombolytic therapy for acute myocardial infarction. In TIME-II Investigators. Intravenous nPA for Treatment of Infarcting Myocardium Early-II","volume":"86","author":"de Lemos","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0265","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1001\/jama.288.10.1252","article-title":"Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study","volume":"288","author":"Vasan","year":"2002","journal-title":"Jama"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0270","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.amjcard.2005.10.020","article-title":"Usefulness of preprocedural serum N-terminal pro-brain natriuretic peptide levels to predict long-term outcome after percutaneous coronary intervention in patients with normal troponin T levels","volume":"97","author":"Saleh","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0275","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1016\/j.jacc.2007.02.064","article-title":"Percutaneous coronary revascularization reduces plasma N-terminal pro-B-type natriuretic peptide concentration in stable coronary artery disease","volume":"49","author":"McClure","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0280","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1053\/ajkd.2003.50118","article-title":"B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study","volume":"41","author":"McCullough","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0285","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jacc.2005.10.038","article-title":"Relationship between renal function and plasma brain natriuretic peptide in patients with heart failure","volume":"47","author":"Tsutamoto","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0290","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.CIR.0000112582.16683.EA","article-title":"Impact of obesity on plasma natriuretic peptide levels","volume":"109","author":"Wang","year":"2004","journal-title":"Circulation"},{"issue":"12Pt 2","key":"10.1097\/MAJ.0b013e31816b874b_bb0295","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1097\/00004872-199715120-00074","article-title":"Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients","volume":"15","author":"Dessi-Fulgheri","year":"1997","journal-title":"J Hypertens"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0300","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1161\/01.CIR.0000079170.10579.DC","volume":"108","author":"James","year":"2003","journal-title":"Circulation"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0305","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.ahj.2006.07.010","article-title":"B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide are depressed in obesity despite higher left ventricular end diastolic pressures","volume":"152","author":"Taylor","year":"2006","journal-title":"Am Heart J"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0310","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/j.jacc.2003.10.066","article-title":"Obesity and suppressed B-type natriuretic peptide levels in heart failure","volume":"43","author":"Mehra","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0315","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0002-9149(02)02464-5","article-title":"Impact of age and sex on plasma natriuretic peptide levels in healthy adults","volume":"90","author":"Wang","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0320","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/107424840200700308","article-title":"Nesiritide: a new drug for the treatment of decompensated heart failure","volume":"7","author":"Elkayam","year":"2002","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0325","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1067\/mhj.2002.125620","article-title":"Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study","volume":"144","author":"Burger","year":"2002","journal-title":"Am Heart J"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0330","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/BF02938348","article-title":"Safety and efficacy of nesiritide for acute decompensated heart failure: recent literature and upcoming trials","volume":"9","author":"Hiestand","year":"2007","journal-title":"Curr Cardiol Rep"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0335","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jacc.2005.03.051","article-title":"In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"46","author":"Abraham","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0340","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.amjcard.2004.05.022","article-title":"Safety and feasibility of using serial infusions of nesiritide for heart failure in an outpatient setting (from the FUSION I trial)","volume":"94","author":"Yancy","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0345","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.amjcard.2006.01.081","article-title":"Potential applications of outpatient nesiritide infusions in patients with advanced heart failure and concomitant renal insufficiency (from the Follow-Up Serial Infusions of Nesiritide [FUSION I] trial)","volume":"98","author":"Yancy","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0350","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ahj.2007.02.004","article-title":"The Second Follow-up Serial Infusions of Nesiritide (FUSION II) trial for advanced heart failure: study rationale and design","volume":"153","author":"Yancy","year":"2007","journal-title":"Am Heart J"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0355","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ejheart.2007.04.004","article-title":"Clinical trials update from the American College of Cardiology 2007: ALPHA, EVEREST, FUSION II, VALIDD, PARR-2, REMODEL, SPICE, COURAGE, COACH, REMADHE, pro-BNP for the evaluation of dyspnoea and THIS-diet","volume":"9","author":"Cleland","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0360","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1471-2261-7-37","article-title":"Outcomes of patients hospitalized for acute decompensated heart failure: does nesiritide make a difference?","volume":"7","author":"Carroll","year":"2007","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0365","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jacc.2006.10.048","article-title":"Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery:the NAPA Trial","volume":"49","author":"Mentzer","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1097\/MAJ.0b013e31816b874b_bb0370","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.cardfail.2005.01.009","article-title":"Effects of intravenous nesiritide on pulmonary vascular hemodynamics in pulmonary hypertension","volume":"11","author":"Michaels","year":"2005","journal-title":"J Card Fail"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915322837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915322837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,12]],"date-time":"2021-09-12T00:07:38Z","timestamp":1631405258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962915322837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":73,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0002962915322837"],"URL":"https:\/\/doi.org\/10.1097\/maj.0b013e31816b874b","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}